AN Venture Partners (ANV), a global biotech venture capital fund, has announced the promotion of Olivia Laxton to Associate, effective immediately.
Olivia joined ANV as a Fellow in June 2025 during her doctoral research and has since become a full-time member of the investment team. In this role, she supports ANV's investment and company creation activities.
"We are delighted to welcome Olivia as a full member of our team. Throughout her time as a Fellow, she contributed to ANV's work with exceptional expertise and dedication. We look forward to her continued contributions as we advance our mission of driving the growth of Japan's biotechnology ecosystem," said Ken Horne, Managing Partner.
Olivia said: "I am truly honored to be stepping into a full-time Associate role after my time as a Fellow. I have learned so much from seeing how the team combines strategic thinking with a genuine commitment to the work - whether identifying innovative science or supporting biotech companies. I hope to keep playing a part in bringing exceptional Japanese science to the world and expanding treatment options for patients"
